Results 211 to 220 of about 78,245 (294)

Trends and characteristics during 17 years of naloxone distribution and administration through an overdose prevention program in Pittsburgh, Pennsylvania. [PDF]

PLoS One
Dasgupta N, Bell A, Visnich M, Doe-Simkins M, Wheeler E, Sibley AL, Nocera M, Seitz AE, Chang D, Barlow S, Dezman ZDW, McAninch JK.   +11 more
europepmc   +1 more source

Impact of a brief personally tailored opioid-overdose and medication for opioid use disorder education intervention on naloxone acceptance in peripartum individuals: A secondary exploratory analysis. [PDF]

J Subst Use Addict Treat
Lofwall MR, Kropp F, Charles J, Cochran G, Douaihy A, Edwards M, Lewis D, Rosa C, Young JL, Winhusen TJ.   +9 more
europepmc   +1 more source

Postoperative naloxone administration in spinal patients: A retrospective analysis of a single institution’s experience

Shao, Manlin , Sheldon, Breanna L. , Luo, Emily , Gillespie, Erica , Bouchal, Elise , Pilitsis Julie G.
openalex   +1 more source

Utilizing Naloxone Education to Reduce the Mortality and Morbidity Rate of Overdose Deaths Within Opioid-Exposed Populations [PDF]

Anna M Marchek, Jedamiah Wolf, Georgia H. O’Leary, Gabriela Pages, Madison C Benefield, Barbara A. Bennett, P. Arunkumar, Marc Burrows, David T. Redden, Alexis M. Stoner, J. N. Cashman   +10 more
openalex   +1 more source

Evaluating the impact of the risk-mitigation guidance for opioid prescribing in British Columbia, Canada using a cross-model comparison approach: study protocol. [PDF]

BMJ Open
Flynn MJ, Mustafa H, Enns B, Karugaba M, Carter A, Guerra-Alejos BC, Slaunwhite A, Nosyk B, Irvine MA.   +8 more
europepmc   +1 more source

Naloxone Disparities in Adolescents: Access Laws Are Not Enough. [PDF]

J Pediatr Pharmacol Ther
Habermann S, Mazer-Amirshahi M, Toce MS.
europepmc   +1 more source

Is Fentanyl Rebound an Intrinsic Feature of Naloxone Reversal? [PDF]

Pharmaceuticals (Basel)
Voronkov M, Nikonov G, Uzbil M, Milevich G, Abernethy J, Barthélémy I.   +5 more
europepmc   +1 more source

From fairytale to clinical practice: A response to commentaries. [PDF]

Addiction
Gonzalez Utrilla M, Chesney E, Neale J, Metrebian N, Kalk N, Skulberg AK, Dietze P, Smith M, Strang J.   +8 more
europepmc   +1 more source

Organize and mobilize for implementation effectiveness to improve overdose education and naloxone distribution from syringe services programs: a randomized controlled trial [PDF]

Barrot H. Lambdin, Ricky N. Bluthenthal, Bryan R. Garner, Lynn D. Wenger, Erica N. Browne, Terry Morris, Lee Ongais, Cariné E. Megerian, Alex H. Kral   +8 more
openalex   +1 more source

Witnessed overdose history and response among overdose survivors who use non-prescribed opioids in an overdose prevention trial. [PDF]

Addict Behav
McCann NC, Yan S, McMahan VM, Rich ZC, Pope E, Rolles A, Brennan S, Marti XL, Kosakowski S, Matheson T, Coffin PO, Walley AY.   +11 more
europepmc   +1 more source